Carbidopa (monohydrate) (Standard)

Carbidopa (monohydrate) (Standard)

• CAS Number: 38821-49-7
• UNSPSC Description: Carbidopa (monohydrate) (Standard) is the analytical standard of Carbidopa (monohydrate). This product is intended for research and analytical applications. Carbidopa ((S)-(-)-Carbidopa) monohydrate, a peripheral decarboxylase inhibitor, can be used for the research of Parkinson's disease. Carbidopa monohydrate is a selective aryl hydrocarbon receptor (AhR) modulator. Carbidopa monohydrate inhibits pancreatic cancer cell and tumor growth[1][2].
• Target Antigen: Aryl Hydrocarbon Receptor
• Type: Reference compound
• Related Pathways: Immunology/Inflammation
• Field of Research: Cancer; Neurological Disease
• Assay Protocol: https://www.medchemexpress.com/carbidopa-monohydrate-standard.html
• Smiles: OC1=C(O)C=CC(C[C@](C)(NN)C(O)=O)=C1.O
• Molecular Weight: 244.24
• References & Citations: [1]Safe S. Carbidopa: a selective Ah receptor modulator (SAhRM). Biochem J. 2017;474(22):3763-3765. Published 2017 Nov 6.|[2]Fermaglich J. Treatment of Parkinson's disease with carbidopa, a peripheral decarboxylase inhibitor, and levodopa. Med Ann Dist Columbia. 1974;43(12):587-591.|[3]Gilbert JA, et al. The aromatic-L-amino acid decarboxylase inhibitor carbidopa is selectively cytotoxic to human pulmonary carcinoid and small cell lung carcinoma cells. Clin Cancer Res. 2000;6(11):4365-4372.
• Shipping Conditions: Room temperature